drugset / Trial / NCT01133080

Minocycline as an Adjunctive Therapy for Schizophrenia: a Randomized Controlled Study

NCT01133080

Phase 4 Unknown 50 enrolled Shalvata Mental Health Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Double - Blind, Randomized, single centered study. The purpose of this study is to assess the feasibility of minocycline vs. placebo, added to atypical antipsychotic medications, for positive symptoms in adults suffering from schizophrenia.

Timeline

Start
2010-06
Primary completion
2013-01
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Minocycline Small molecule 400 mg Oral

Indications